A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease
Clinical trial NCT07399704 · RECRUITING
Trial details
- NCT number
- NCT07399704
- Sponsor
- Azafaros B.V.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-04
- Primary completion
- 2030-04-15
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.